The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pediatric Psoriasis Treatment Market Research Report 2024
Synopsis
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
Global Pediatric Psoriasis Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Psoriasis Treatment market research.
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pediatric Psoriasis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AbbVie
Amgen
Johnson and Johnson
Novartis AG
Eli Lilly and Company
AstraZeneca
Celgene Corporation
UCB
Merck
Boehringer Ingelheim
LEO Pharma
Qingdao Vland Biotech
Yunnan Botanee Bio-Technology
Furen Group
Jiangsu Kanion Pharmaceutical
Tianjin Pacific Pharmaceutical
Segment by Type
Topical Treatment
Systemic Treatment
Segment by Application
Psoriasis Vulgaris
Pustular Psoriasis
Erythrodermic Psoriasis
Arthropathic Psoriasis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pediatric Psoriasis Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
Global Pediatric Psoriasis Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pediatric Psoriasis Treatment market research.
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pediatric Psoriasis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AbbVie
Amgen
Johnson and Johnson
Novartis AG
Eli Lilly and Company
AstraZeneca
Celgene Corporation
UCB
Merck
Boehringer Ingelheim
LEO Pharma
Qingdao Vland Biotech
Yunnan Botanee Bio-Technology
Furen Group
Jiangsu Kanion Pharmaceutical
Tianjin Pacific Pharmaceutical
Segment by Type
Topical Treatment
Systemic Treatment
Segment by Application
Psoriasis Vulgaris
Pustular Psoriasis
Erythrodermic Psoriasis
Arthropathic Psoriasis
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pediatric Psoriasis Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Pediatric Psoriasis Treatment Market Overview
1.1 Product Overview and Scope of Pediatric Psoriasis Treatment
1.2 Pediatric Psoriasis Treatment Segment by Type
1.2.1 Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Topical Treatment
1.2.3 Systemic Treatment
1.3 Pediatric Psoriasis Treatment Segment by Application
1.3.1 Global Pediatric Psoriasis Treatment Market Value by Application: (2023-2029)
1.3.2 Psoriasis Vulgaris
1.3.3 Pustular Psoriasis
1.3.4 Erythrodermic Psoriasis
1.3.5 Arthropathic Psoriasis
1.4 Global Pediatric Psoriasis Treatment Market Size Estimates and Forecasts
1.4.1 Global Pediatric Psoriasis Treatment Revenue 2018-2029
1.4.2 Global Pediatric Psoriasis Treatment Sales 2018-2029
1.4.3 Global Pediatric Psoriasis Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pediatric Psoriasis Treatment Market Competition by Manufacturers
2.1 Global Pediatric Psoriasis Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pediatric Psoriasis Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pediatric Psoriasis Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Pediatric Psoriasis Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pediatric Psoriasis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Psoriasis Treatment, Product Type & Application
2.7 Pediatric Psoriasis Treatment Market Competitive Situation and Trends
2.7.1 Pediatric Psoriasis Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pediatric Psoriasis Treatment Players Market Share by Revenue
2.7.3 Global Pediatric Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Psoriasis Treatment Retrospective Market Scenario by Region
3.1 Global Pediatric Psoriasis Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pediatric Psoriasis Treatment Global Pediatric Psoriasis Treatment Sales by Region: 2018-2029
3.2.1 Global Pediatric Psoriasis Treatment Sales by Region: 2018-2023
3.2.2 Global Pediatric Psoriasis Treatment Sales by Region: 2024-2029
3.3 Global Pediatric Psoriasis Treatment Global Pediatric Psoriasis Treatment Revenue by Region: 2018-2029
3.3.1 Global Pediatric Psoriasis Treatment Revenue by Region: 2018-2023
3.3.2 Global Pediatric Psoriasis Treatment Revenue by Region: 2024-2029
3.4 North America Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.4.1 North America Pediatric Psoriasis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pediatric Psoriasis Treatment Sales by Country (2018-2029)
3.4.3 North America Pediatric Psoriasis Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.5.1 Europe Pediatric Psoriasis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pediatric Psoriasis Treatment Sales by Country (2018-2029)
3.5.3 Europe Pediatric Psoriasis Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Pediatric Psoriasis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pediatric Psoriasis Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Pediatric Psoriasis Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.7.1 Latin America Pediatric Psoriasis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pediatric Psoriasis Treatment Sales by Country (2018-2029)
3.7.3 Latin America Pediatric Psoriasis Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Psoriasis Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Psoriasis Treatment Sales by Type (2018-2029)
4.1.1 Global Pediatric Psoriasis Treatment Sales by Type (2018-2023)
4.1.2 Global Pediatric Psoriasis Treatment Sales by Type (2024-2029)
4.1.3 Global Pediatric Psoriasis Treatment Sales Market Share by Type (2018-2029)
4.2 Global Pediatric Psoriasis Treatment Revenue by Type (2018-2029)
4.2.1 Global Pediatric Psoriasis Treatment Revenue by Type (2018-2023)
4.2.2 Global Pediatric Psoriasis Treatment Revenue by Type (2024-2029)
4.2.3 Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Pediatric Psoriasis Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pediatric Psoriasis Treatment Sales by Application (2018-2029)
5.1.1 Global Pediatric Psoriasis Treatment Sales by Application (2018-2023)
5.1.2 Global Pediatric Psoriasis Treatment Sales by Application (2024-2029)
5.1.3 Global Pediatric Psoriasis Treatment Sales Market Share by Application (2018-2029)
5.2 Global Pediatric Psoriasis Treatment Revenue by Application (2018-2029)
5.2.1 Global Pediatric Psoriasis Treatment Revenue by Application (2018-2023)
5.2.2 Global Pediatric Psoriasis Treatment Revenue by Application (2024-2029)
5.2.3 Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Pediatric Psoriasis Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Pediatric Psoriasis Treatment Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Pediatric Psoriasis Treatment Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Corporation Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson and Johnson Pediatric Psoriasis Treatment Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Pediatric Psoriasis Treatment Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Corporation Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly and Company Pediatric Psoriasis Treatment Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AstraZeneca Pediatric Psoriasis Treatment Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Celgene Corporation
6.6.1 Celgene Corporation Corporation Information
6.6.2 Celgene Corporation Description and Business Overview
6.6.3 Celgene Corporation Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Celgene Corporation Pediatric Psoriasis Treatment Product Portfolio
6.7.5 Celgene Corporation Recent Developments/Updates
6.8 UCB
6.8.1 UCB Corporation Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 UCB Pediatric Psoriasis Treatment Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck Pediatric Psoriasis Treatment Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Boehringer Ingelheim Pediatric Psoriasis Treatment Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 LEO Pharma
6.11.1 LEO Pharma Corporation Information
6.11.2 LEO Pharma Pediatric Psoriasis Treatment Description and Business Overview
6.11.3 LEO Pharma Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 LEO Pharma Pediatric Psoriasis Treatment Product Portfolio
6.11.5 LEO Pharma Recent Developments/Updates
6.12 Qingdao Vland Biotech
6.12.1 Qingdao Vland Biotech Corporation Information
6.12.2 Qingdao Vland Biotech Pediatric Psoriasis Treatment Description and Business Overview
6.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Qingdao Vland Biotech Pediatric Psoriasis Treatment Product Portfolio
6.12.5 Qingdao Vland Biotech Recent Developments/Updates
6.13 Yunnan Botanee Bio-Technology
6.13.1 Yunnan Botanee Bio-Technology Corporation Information
6.13.2 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Description and Business Overview
6.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product Portfolio
6.13.5 Yunnan Botanee Bio-Technology Recent Developments/Updates
6.14 Furen Group
6.14.1 Furen Group Corporation Information
6.14.2 Furen Group Pediatric Psoriasis Treatment Description and Business Overview
6.14.3 Furen Group Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Furen Group Pediatric Psoriasis Treatment Product Portfolio
6.14.5 Furen Group Recent Developments/Updates
6.15 Jiangsu Kanion Pharmaceutical
6.15.1 Jiangsu Kanion Pharmaceutical Corporation Information
6.15.2 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Description and Business Overview
6.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product Portfolio
6.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.16 Tianjin Pacific Pharmaceutical
6.16.1 Tianjin Pacific Pharmaceutical Corporation Information
6.16.2 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Description and Business Overview
6.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product Portfolio
6.16.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Psoriasis Treatment Industry Chain Analysis
7.2 Pediatric Psoriasis Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Psoriasis Treatment Production Mode & Process
7.4 Pediatric Psoriasis Treatment Sales and Marketing
7.4.1 Pediatric Psoriasis Treatment Sales Channels
7.4.2 Pediatric Psoriasis Treatment Distributors
7.5 Pediatric Psoriasis Treatment Customers
8 Pediatric Psoriasis Treatment Market Dynamics
8.1 Pediatric Psoriasis Treatment Industry Trends
8.2 Pediatric Psoriasis Treatment Market Drivers
8.3 Pediatric Psoriasis Treatment Market Challenges
8.4 Pediatric Psoriasis Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
